Haleos Labs (BOM:540679) Short-Term Debt: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540679 Haleos Labs Ltd BOM:540679
69 GF Score
Price ₹1,497.50
GF Value ₹1,148.08
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Haleos Labs Short-Term Debt?

Haleos Labs BOM:540679 69 Short-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:540679 with a GF Score™ of 69/100 and a GF Value™ of ₹1,148.08 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Haleos Labs's Short-Term Debt for the quarter that ended in Jun. 2026 was ₹0 Mil.

Haleos Labs's quarterly Short-Term Debt increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹589 Mil) but then declined from Mar. 2026 (₹589 Mil) to Jun. 2026 (₹0 Mil).

Haleos Labs's annual Short-Term Debt increased from Mar. 2024 (₹646 Mil) to Mar. 2025 (₹657 Mil) but then declined from Mar. 2025 (₹657 Mil) to Mar. 2026 (₹589 Mil).

Haleos Labs Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Haleos Labs Short-Term Debt Related Terms

Haleos Labs Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Haleos Labs's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleos Labs Short-Term Debt Chart

Haleos Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 369.33 436.95 645.66 657.47 588.95

Haleos Labs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 549.95 0.00 588.95 0.00
BOM:540679
69GF Score
Haleos Labs Ltd BOM:540679
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ₹0 Mil mean?
Haleos Labs (BOM:540679) has a Short-Term Debt of ₹0 Mil as of Jun. 2026.
Is Haleos Labs' Short-Term Debt too high?
Haleos Labs' current Short-Term Debt is ₹0 Mil. Overall, Haleos Labs has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Haleos Labs' Short-Term Debt compare to VRTX and REGN?
Haleos Labs' Short-Term Debt of ₹0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Biotechnology company?
A good Short-Term Debt depends on the Biotechnology industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Haleos Labs's current Short-Term Debt is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleos Labs stock overvalued right now?
Based on GuruFocus' analysis, Haleos Labs (BOM:540679) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,148.08, compared to a current price of ₹1,497.50 — trading 30.4% above its estimated fair value. The current Short-Term Debt is ₹0 Mil. Haleos Labs' overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Haleos Labs (BOM:540679), the current Short-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleos Labs (BOM:540679) Overvalued in 2026?

Based on GuruFocus' analysis, Haleos Labs stock appears to be overvalued. The current stock price of ₹1,497.50 is trading 30.4% above its estimated GF Value™ of ₹1,148.08. GuruFocus considers Haleos Labs to be Significantly Overvalued.

Key valuation signals for BOM:540679:

  • Short-Term Debt: ₹0 Mil
  • GF Value™: ₹1,148.08 vs. price of ₹1,497.50 (30.4% above fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the BOM:540679 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haleos Labs Business Description

Other Exchanges HALEOSLABS:India
Address Road Number 71, Plot Number 19 - III, Opposite Bharatiya Vidya Bhavan Public School, Jubilee Hills, Hyderabad, TG, IND, 500096
Haleos Labs Ltd is engaged in the Business of manufacturing Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, Anti Obesity, Anesthesia, and others. The company has manufacturing facilities at Kazipally and Jeedimetla and its Research and Development center at Sanatnagar in Hyderabad.
69GF Score

Get the complete analysis for BOM:540679

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,497.50
Price
₹1,148.08
GF Value